AAO 2025 Meeting Highlights
The American Academy of Ophthalmology (AAO) held its annual scientific meeting in Orlando, Florida, featuring new technologies and ongoing research.
Researchers from Massachusetts Eye and Ear presented a study using the TriNetX network, analyzing electronic health records of over 17,000 patients with xanthelasma and a control group.
- Xanthelasma group showed a 14% risk of cardiovascular events, compared to 11.8% in the control group.
- Xanthelasma group had a higher rate of high cholesterol or lipid disorders (50% vs 38%).
Effects of GLP-1 drugs on eye health and a potential sign of cardiovascular disease were discussed.
Ophthalmology Times highlights key stories from the meeting, including the impact of xanthelasma on cardiovascular health.
Author summary: AAO 2025 meeting showcases new technologies and research.